RXR agonist modulates TR: Corepressor dissociation upon 9-cis retinoic acid treatment

Molecular Endocrinology

Volumn 29, Issue 2, 2015, Pages 258-273

  Fattori, Juliana ^a   Campos, Jéssica L O ^a   Doratioto, Tábata R ^a   Assis, Lucas M ^a   Vitorino, Mariela T ^a   Polikarpov, Igor ^b   Xavier Neto, José ^a   Figueira, Ana Carolina M ^a  

^a BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; DNA; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; COREPRESSOR PROTEIN; MULTIPROTEIN COMPLEX; RETINOIC ACID; TRYPTOPHAN;

ARTICLE; BINDING AFFINITY; CELL ASSAY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA BINDING; GEL PERMEATION CHROMATOGRAPHY; HINGE REGION; HUMAN; HUMAN CELL; LIGHT SCATTERING; PRIORITY JOURNAL; PROTEIN STABILITY; STOICHIOMETRY; X RAY CRYSTALLOGRAPHY; AGONISTS; ANISOTROPY; BIOLOGICAL MODEL; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECTS; FLUORESCENCE; GENETICS; HEK293 CELL LINE; METABOLISM; PHOTON CORRELATION SPECTROSCOPY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SIZE EXCLUSION CHROMATOGRAPHY; SMALL ANGLE SCATTERING; TRANSCRIPTION INITIATION; ULTRACENTRIFUGATION; X RAY DIFFRACTION;

ANISOTROPY; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; CO-REPRESSOR PROTEINS; DNA; DYNAMIC LIGHT SCATTERING; FLUORESCENCE; HEK293 CELLS; HUMANS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROID HORMONE; RETINOID X RECEPTORS; SCATTERING, SMALL ANGLE; TRANSCRIPTIONAL ACTIVATION; TRETINOIN; TRYPTOPHAN; ULTRACENTRIFUGATION; X-RAY DIFFRACTION;

EID: 84922311075     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1251     Document Type: Article

References (82)

1. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrinol Rev. 1993;14:184–193.
2. Boelen A, Kwakkel J, Filers E. Thyroid hormone receptors in health and disease. Minerva Endocrinol. 2012;37:291–304.
3. Chen Y, Young MA. Structure of a thyroid hormone receptor DNAbinding domain homodimer bound to an inverted palindromeDNA response element. Mol Endocrinol. 2010;24:1650–1664.
4. Ikeda M, Myungchull R, Chin WW. Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements. Endocrinology. 1994;135:1628–1638.
5. Lazar MA, Berrodin TJ, Harding HP. Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor. Mol Cell Biol. 1991;11:5005–5015.
6. Williams GR, Zavacki AM, Harney JW, Brent GA. Thyroid hormone receptor binds with unique properties to response elements that contain hexamer domains in an inverted palindrome arrangement. Endocrinology. 1994;134:1888–1896.
7. Piedrafita FJ, Bindik I, Ortiz MA, Pfahl M. Thyroid hormone receptor homodimers can function as ligand-sensitive repressors. Mol Endocrinol. 1995;9:563–578.
8. Brent GA, Williams GR, Harney JW, et al. Capacity for cooperative binding of thyroid hormone (T3) receptor dimers defines wild type T3 response elements. Mol Endocrinol. 1992;6:502–514.
9. Ribeiro RC, Kushner PJ, Apriletti JW, West BL, Baxter JD. Thyroid hormone alters in vitro DNA binding of monomers and dimers of thyroid hormone receptors. Mol Endocrinol. 1992;6:1142–1152.
10. Bendik I, Pfahl M. Similar ligand-induced conformational changes of thyroid hormone receptors regulate homo- and heterodimeric functions. J Biol Chem. 1995;270:3107–3114.
11. Figueira ACM, Polikarpov I, Veprintsev D, Santos GM. Dissecting the relation between a nuclear receptor and GATA: binding affinity studies of thyroid hormone receptor and GATA2 on TSHb promoter. PLoS One. 2010;5:e12628.
12. Agaard MM, Siersbaek R, Mandrup S. Molecular basis for genespecific transactivation by nuclear receptors. Biochim Biophys Acta. 2011;1812:824–835.
13. Nagy L, Schwabe JWR. Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci. 2004;29:317–324.
14. Santos GM, Fairall L, Schwabe JWR. Negative regulation by nudoiclear receptors: a plethora of mechanisms. Trends Endocrinol Metab. 2011;22:87–93.
15. Bagamasbad P, Denver RJ. Mechanisms and significance of nuclear receptor auto- and cross-regulation. Gen Comp Endocrinol. 2011; 170:3–17.
16. Huang P, Chandra V, Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol. 2010;72:247–272.
17. Rastinejad F, Huang P, Chandra V, Khorasanizadeh S. Understanding nuclear receptor form and function using structural biology. J Mol Endocrinol. 2013;51:T1–T21.
18. Chandra V, Huang P, Hamuro Y, et al. Structure of the intact PPAR-_-RXR-nuclear receptor complex on DNA. Nature. 2008; 456:350–356.
19. Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F. Multidomain integration in the structure of the HNF-4_ nuclear receptor complex. Nature. 2013;495:394–398.
20. Lou X, Toresson G, Benod C, et al. Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA. Nat Struct Mol Biol. 2014;21:277–281.
21. Leo C, Li H, Chen, JD. Differential mechanisms of nuclear receptor regulation by receptor-associated coactivator 3. J. Biol. Chem. 2000;275:5976–5982.
22. Darimont BD, Wagner RL, Apriletti JW, et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998;12:3343–3356.
23. Bulynko YA, O’Malley BW. Nuclear receptors coactivators: structural and functional biochemistry. Biochemistry. 2011;50:313–328.
24. Ko L, Cardona GR, Henrion-Caude A, Chin WW. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Mol Cell Biol. 2002;22:357–369.
25. Lefebvre P, Benomar Y, Staels B. Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab. 2010;21:676–683.
26. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature. 1992;358:771–774.
27. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841–850.
28. Lee S, Privalsky ML. Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Mol Endocrinol. 2005;4:863–878.
29. Diallo EM, Thompson DL, Koenig RJ. A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer-DNA binding is enhanced by the coactivator TIF 2. Protein Express Purif. 2005;40:292–298.
30. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 1995;81:541–550.
31. Putcha BDK, Wright E, Brunzelle JS, Fernandez EJ. Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers. Proc Natl Acad Sci USA. 2012;109:6084–6087.
32. Puzianowska-Kuzincka M, Damjanovski S, Shi Y-B. Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis. Mol Cell Biol. 1997; 17:4738–4749.
33. Putcha BDK, Fernandez EJ. Direct interdomain interactions can mediate allosterism in the thyroid receptor. J Biol Chem. 2009;284: 22517–22524.
34. Castillo AI, Sánchez-Matínez R, Moreno JL, Martínez-Iglesias OA, Palacios D, Aranda A. A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis retinoic acid. Mol Cell Biol. 2004;24:502–513.
35. Li D, Li T, Wang F, Tian H, Samuels HH. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer. Mol Cell Biol. 2002;22: 5782–5792.
36. Li D, Yamada T, Wang F, Vulin AI, Samuels HH. Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer. J Biol Chem. 2004;279:7427–7437.
37. Seigel LM, Monty KJ. Determination of molecular weights and fractional ratios of proteins in impure systems by use of gel-filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases. Biochim Biophys Acta. 1966;112:346–362.
38. Whitmore L, Wallace BA. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers. 2008;89:392–400.
39. Whitmore L, Wallace BA. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 2004;32:W668–W673.
40. Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc. 2007;2:2212–2221.
41. Schuck P. Size distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J. 2000;78:1606–1619.
42. Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI. PRIMUS—a Windows-PC based system for small-angle scattering data analysis. J Appl Cryst. 2003;36:1277–1282.
43. Svergun DI. Determination of the regularization parameter in indirect- transform methods using perceptual criteria. J Appl Crystallogr. 1992;25:495–503.
44. Svergun DI. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys J. 1999;76:2879–2886.
45. Konarev PV, Petoukhov MV, Volkov VV, Svergun DI. ATSAS 2.1, a program package for small-angle scattering data analysis. J Appl Crystallol. 2006–39:277–286.
46. Putnam CD, Hammel M, Hura GL, Tainer JA. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q Rev Biophys. 2007 40:191–285.
47. Figueira ACM, Lima LMTR, Lima, LHF, Ranzani AT, Mule GS, Polikarpov I. Recognition by the thyroid hormone receptor of canonical DNA response elements. Biochemistry. 2010;49:893–904.
48. Lupisella JA, Driscoll JE, Metzler WJ, Reckzec PR. The ligand binding domain of the human retinoic acid receptor _ is predominantly _-helical with a Trp residue in the ligand binding site. J Biol Chem. 1995;270:24884–24890.
49. Wang Y, Lonard DM, Yu Y, Chow D-C, Palzkill TG, O’Malley BW. Small Molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol Endocrinol. 2011;25:2041–2053.
50. van de Weert M. Fluorescence quenching to study protein-ligand binding. J Fluoresc. 2010;20:625–629.
51. Feng W, Ribeiro RCJ, Wagner RL, et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 1998;5370:1747–1749.
52. Velasco LF, Togashi M, Walfish PG, et al. Thyroid hormone response element organization dictates the composition of active receptor. J Biol Chem. 2007;282:12458–12466.
53. Ribeiro RCJ, Feng W, Wagner RL, et al. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. J Biol Chem. 2001;276:14987–14995.
54. Figueira ACM, Saidemberg DM, Souza PCT, et al. Analysis of agonist and antagonist effects on thyroid hormone receptor confor-mation by hydrogen/deuterium exchange. Mol Endocrinol. 2011; 25:15–31.
55. Tagami T, Gu W-X, Peairs PT, West BL, Jameson JL. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol. 1998;12:1888–1902.
56. Bourguet W, Ruff M, Chambom P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature. 1995;375:377–382.
57. Ericsson UB, Hallberg BM, Detitta GT, Dekker N, Nordlund P. Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem. 2006;357:289–298.
58. Figueira AC, Dias SM, Santos MA, et al. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding. Cell Biochem Biophys. 2006;44:453–462.
59. Kersten S, Pan L, Noy N. On the role of ligand in retinoid signaling: positive cooperativity in the interactions of 9-cis retinoic acid with tetramers of the retinoid X receptor. Biochemistry. 1995;34: 14263–14269.
60. Zhang X, Lehmann J, Hoffmann B, et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature. 1992; 358:587–591.
61. Lehmann J, Zhang X, Graupner G, et al. Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching. Mol Cell Biol. 1993;13: 7698–7707.
62. Vivat-Hannah V, Bourguet W, Gottardis M, Gronemeyer H. Separation of retinoid X receptor homo- and heterodimerization functions. Mol Cell Biol. 2003;23:7678–7688.
63. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81:1269–1304.
64. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG. RXRα, a promiscuous partner of retinoid acid and thyroid hormone receptors. EMBO J. 1992;11:1409–1418.
65. Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoid acid receptors. Nature. 1992;355:441–446.
66. Germains P, Iyer J, Zechel C, Gronemeyer H. Coregulator recruitment and the mechanism of retinoid acid receptor synergy. Nature. 2002;415:187–192.
67. Sato Y, Ramalanjaona N, Huet T, et al. The “phantom effect” of the rexinoid LG100754: structural and functional insights. PLoS One. 2010;5:e15119.
68. Forman BM, Samuels HH. Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol Endocrinol. 1990;4:1293–1301.
69. Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell. 2004;116:417–429.
70. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev. 2004;3:950–964.
71. Schulman IG, Li C, Shwabe JWR, Evans RM. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 1997;11:299–308.
72. Hallenbeck PL, Phyillaier M, Nikodem VM. Divergent effects os 9-cis-retinoic acid receptor on positive and negative thyroid hormone receptor-dependent gene expression. J Biol Chem. 1993;268: 3825–3828.
73. Simões-Costa MS, Azambuja AP, Xavier Neto J. The search for non-chordate retinoic acid signaling: lessons from chordates. J. Exp. Zool. 2008;310B:54–72.
74. Nolte RT, Wisley GB, Westin S, et al. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor- γ. Nature. 1998;395:137–143.
75. Le Douarin B, Zechel C, Garnier JM, et al. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T 18. EMBO J. 1995;14:2020–2033.
76. Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-_ and estrogen receptor-_: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology. 2000;141:3534–3545.
77. Hall JM, McDonnell P, Korach KS. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol. 2002;16: 469–486.
78. Hilser VJ, Thompson EB. Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors. J Biol Chem. 2011;286:39675–39682.
79. Zhang J, Chalmers MJ, Stayrook KR, et al. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol. 2011;18:556–564.
80. Varlakhanova N, Snyder C, Jose S, Hahm JB, Privalsky ML. Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain. Mol Cell Biol. 2010;30:1434–1445.
81. McInerney EM, Tsai MJ, O’Malley BW, Katzenellenbogen BS. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA. 1996; 93:10069–10073.
82. Oñate SA, Boonyaratanakornkit V, Spencer TE, et al. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1(AF1) and AF2 domains of steroid receptors. J Biolsuppl Chem. 1998;273:12101–12108.